Although tested in only one patient, superior MHC-I restricted anti-tumor effector activity of the IL-21 aAPC expanded CD8+ T cells could also be confirmed by IFN-γ secretion upon exposure to autologous melanoma cells. The gene discussed is CD8A; the disease is melanoma.